YAP/TAZ-associated cell signaling – at the crossroads of cancer and neurodevelopmental disorders
YAP/TAZ (Yes-associated protein/paralog transcriptional co-activator with PDZ-binding domain) are transcriptional cofactors that are the key and major downstream effectors of the Hippo signaling pathway. Both are known to play a crucial role in defining cellular outcomes, including cell differentiat...
Saved in:
Main Authors: | Aderonke O. Ajongbolo, Sigrid A. Langhans |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-01-01
|
Series: | Frontiers in Cell and Developmental Biology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcell.2025.1522705/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Fingolimod exerts in vitro anticancer activity against hepatocellular carcinoma cell lines via YAP/TAZ suppression
by: Du Jiamin, et al.
Published: (2022-09-01) -
Exploring the Revolutionary Impact of YAP Pathways on Physical and Rehabilitation Medicine
by: Carmelo Pirri
Published: (2025-01-01) -
Regulation of Hippo-YAP1/TAZ pathway in metabolic dysfunction-associated steatotic liver disease
by: Wei Xuan, et al.
Published: (2025-01-01) -
Transient activation of YAP/TAZ confers resistance to morusin-induced apoptosis
by: Hoyeon Lee, et al.
Published: (2025-01-01) -
Role of YAP/TAZ in bone diseases: A transductor from mechanics to biology
by: Xin Chen, et al.
Published: (2025-03-01)